Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Merck & Company, Inc.

Merck & Company, Inc.

  1. The Participants
    Wall Street Journal logo Wall Street Journal 12 hours ago

    (Chief executives except as noted) José Maria Alapont Federal-Mogul Corp. Mukesh D. Ambani Chairman and Managing Director, Reliance Industries Ltd. George Barrett Cardinal Health Inc. Jeffrey L. Bewkes Time Warner Inc. Full Article at Wall Street Journal

  2. Shop for Dividends in This Bull Market
    Wall Street Journal logo Wall Street Journal 1 day ago

    By Brett Arends Wall Street has rallied a long way since the dark days last winter. Full Article at Wall Street Journal

  3. AP Photo logo AP Photo 2 months ago
    FILE - In this June 17, 2005 file photo, Merck & Co. CEO Richard T. Clark, answers a question at the drug maker's Whitehouse Station, N.J. headquarters.

    FILE - In this June 17, 2005 file photo, Merck & Co. CEO Richard T. Clark, answers a question at the drug maker's Whitehouse Station, N.J. headquarters. View Photo »

  4. Innovation in OLED technology is one of the primary focuses of our institute ... We’re pleased to partner with Applied Materials and Merck to evaluate how our new high-efficiency OLED lighting device structures will perform in an industrial-scale environment.
    SOURCE: PR-Inside.com 5 days ago
  5. Merck & Co.
    Boston Globe logo Boston Globe 1 day ago

    Drug developer Merck’s shares gained after a European advisory committee recommended approval for its fertility drug Elonva. The European Medicines Agency panel made the recommendation. Full Article at Boston Globe

  6. Merck (NYSE: MRK) Receives European Approval of Elonva
    TransWorldNews logo TransWorldNews 1 day ago

    Drug developer Merck & Co. (NYSE: MRK) said Friday a European advisory committee recommended approval for the company's fertility drug Elonva, according to Associated Press. Full Article at TransWorldNews

  7. This Baby Is a Nice Addition
    The Money Times logo The Money Times 2 days ago

    The marriage between Merck (NYSE: MRK) and Schering-Plough is already starting to produce offspring. The only question is whether the fertility treatment for its pipeline was worth it. Full Article at The Money Times

  8. AP Photo logo AP Photo 8 months ago
    Traders look to buy and sell shares of Merck stock at the New York Stock Exchange Wednesday, March 18, 2009, in New York.

    Traders look to buy and sell shares of Merck stock at the New York Stock Exchange Wednesday, March 18, 2009, in New York. View Photo »

  9. We would encourage parents to report any adverse experience associated with any Merck medication or vaccine to their healthcare provider, Merck or the FDA. Patients can report adverse events through their healthcare provider, the Merck National Service Center (1-800-444-2080), or FDA MEDWatch or call 1-...
    SOURCE: Huffington Post 2 weeks ago
  10. Swine Flu Hoax Exposed 2009
    YouTube Logo YouTube Videos 2 months ago
  11. Dell Tumbles 10%; Merck Gains
    Wall Street Journal logo Wall Street Journal 2 days ago

    By Geoffrey Rogow NEW YORK—A bigger-than-expected drop in Dell's latest quarterly earnings and a pullback for global industrials, including Caterpillar, pushed stocks lower Friday, though continued strength for some defensive blue chips like Merck kept... Full Article at Wall Street Journal

  12. Big Pharma Mergers: Good News Or Bad?
    Investor's Business Daily logo Investor's Business Daily 2 days ago

    Whoever says you can't throw money at problems hasn't spent much time following the Big Pharma sector this year. More than $160 billion worth of buyouts involving top drugmakers has already been inked in 2009. Full Article at Investor's Business Daily

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

About Merck & Company, Inc.

Wikipedia

There are no results for this module. Edit this module to change the search term used to query Wikipedia

Related Photos

Traders look to buy and sell shares of Merck stock at the New York Stock Exchange Wednesday, March 18, 2009, in New York.
Pause Play 1/25
prev
  1. FILE - In this June 17, 2005 file photo, Merck & Co. CEO Richard T. Clark, answers a question at the drug maker's Whitehouse Station, N.J. headquarters. AP Photo logo AP Photo 2 months ago

    FILE - In this June 17, 2005 file photo, Merck & Co. CEO Richard T. Clark, answers a question at the drug maker's Whitehouse Station, N.J. headquarters.

    View Photo »
  2. Traders look to buy and sell shares of Merck stock at the New York Stock Exchange Wednesday, March 18, 2009, in New York. AP Photo logo AP Photo 8 months ago

    Traders look to buy and sell shares of Merck stock at the New York Stock Exchange Wednesday, March 18, 2009, in New York.

    View Photo »
  3. In this May 22, 2008 file photo, Merck & Co. headquarters is seen in Whitehouse Station, N.J. Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash, Monday, March 9, 2009, in a deal that gives the companies more firepower to compete in a drug industry facing s... AP Photo logo AP Photo 8 months ago

    In this May 22, 2008 file photo, Merck & Co. headquarters is seen in Whitehouse Station, N.J. Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash, Monday, March 9, 2009, in a deal that gives the companies more firepower to compete in a drug industry facing s...

    View Photo »
  4. This handout image shows the logo for Merck & Co. ,Inc. US pharmaceutical giants Merck and Schering-Plough announced their merger on March 9, 2009 in a stock-and-cash transaction valued at 41.1 billion dollars. Getty Images logo Getty Images 8 months ago

    This handout image shows the logo for Merck & Co. ,Inc. US pharmaceutical giants Merck and Schering-Plough announced their merger on March 9, 2009 in a stock-and-cash transaction valued at 41.1 billion dollars.

    View Photo »
  5. Graphic shows product sales figures for Merck & co. and Schering-Plough Corp. 1c x 5 1/4 inches; 46.5 mm x 133 mm;. AP Photo logo AP Photo 8 months ago

    Graphic shows product sales figures for Merck & co. and Schering-Plough Corp. 1c x 5 1/4 inches; 46.5 mm x 133 mm;.

    View Photo »
  6. A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. �EUTERS/Jeff Zelevansky. Reuters Pictures 8 months ago

    A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. �EUTERS/Jeff Zelevansky.

    View Photo »
  7. A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. Reuters Pictures 8 months ago

    A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines.

    View Photo »
  8. A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. Reuters Pictures 8 months ago

    A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines.

    View Photo »
  9. A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. Reuters Pictures 8 months ago

    A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines.

    View Photo »
  10. Richard Clark, Chairman and C.E.O. of Merck, is shown in this undated handout image released by Merck on March 9, 2009. Reuters Pictures 8 months ago

    Richard Clark, Chairman and C.E.O. of Merck, is shown in this undated handout image released by Merck on March 9, 2009.

    View Photo »
  11. This undated handout image, provided by Merck & Co. Inc. on March 9, 2009, shows the cholesterol drug Vytorin. Reuters Pictures 8 months ago

    This undated handout image, provided by Merck & Co. Inc. on March 9, 2009, shows the cholesterol drug Vytorin.

    View Photo »
  12. This undated handout image, provided by Merck & Co. Inc. on March 9, 2009, shows the cholesterol drug Zetia. Reuters Pictures 8 months ago

    This undated handout image, provided by Merck & Co. Inc. on March 9, 2009, shows the cholesterol drug Zetia.

    View Photo »
  13. Richard Clark, Chairman and C.E.O. of Merck, speaks at the Reuters Health Summit in New York, in this file photo taken November 19, 2008. Reuters Pictures 8 months ago

    Richard Clark, Chairman and C.E.O. of Merck, speaks at the Reuters Health Summit in New York, in this file photo taken November 19, 2008.

    View Photo »
  14. Richard Clark, Chairman and C.E.O. of Merck, speaks at the Reuters Health Summit in New York, in this file image taken November 19, 2008. Reuters Pictures 8 months ago

    Richard Clark, Chairman and C.E.O. of Merck, speaks at the Reuters Health Summit in New York, in this file image taken November 19, 2008.

    View Photo »
  15. Richard Clark, Chairman, President and Chief Executive Officer of Merck & Co. , Inc. , speaks at the Reuters Health Summit in New York, November 10, 2009. Reuters Pictures 1 week ago

    Richard Clark, Chairman, President and Chief Executive Officer of Merck & Co. , Inc. , speaks at the Reuters Health Summit in New York, November 10, 2009.

    View Photo »
  16. Richard Clark, Chairman, President and Chief Executive Officer of Merck & Co. , Inc. , speaks at the Reuters Health Summit in New York, November 10, 2009. Reuters Pictures 1 week ago

    Richard Clark, Chairman, President and Chief Executive Officer of Merck & Co. , Inc. , speaks at the Reuters Health Summit in New York, November 10, 2009.

    View Photo »
  17. File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. AP Photo logo AP Photo 3 months ago

    File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters.

    View Photo »
  18. File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. AP Photo logo AP Photo 3 months ago

    File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters.

    View Photo »
  19. File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. AP Photo logo AP Photo 3 months ago

    File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters.

    View Photo »
  20. In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. AP Photo logo AP Photo 3 months ago

    In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters.

    View Photo »
  21. FILE - In this 2004 file photo provided by Schering-Plough Corp. , the cholesterol-lowering drug Vytorin, the product of a joint venture between pharmaceutical companies Merck & Co. , and Schering-Plough Corp. , is shown. AP Photo logo AP Photo 3 months ago

    FILE - In this 2004 file photo provided by Schering-Plough Corp. , the cholesterol-lowering drug Vytorin, the product of a joint venture between pharmaceutical companies Merck & Co. , and Schering-Plough Corp. , is shown.

    View Photo »
  22. FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington. AP Photo logo AP Photo 4 months ago

    FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington.

    View Photo »
  23. FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington. AP Photo logo AP Photo 4 months ago

    FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington.

    View Photo »
  24. FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington. AP Photo logo AP Photo 4 months ago

    FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington.

    View Photo »
  25. FILE - In this April 28, 2006 file photo, a bottle of Schering-Plough's allergy spray Nasonex is shown in New York. AP Photo logo AP Photo 4 months ago

    FILE - In this April 28, 2006 file photo, a bottle of Schering-Plough's allergy spray Nasonex is shown in New York.

    View Photo »
next
AP Photo logo AP Photo 8 months ago

Traders look to buy and sell shares of Merck stock at the New York Stock Exchange Wednesday, March 18, 2009, in New York.

View Photo »
View All »

Related Topics

  1. Schering Plough Corp Schering Plough Corp
  2. Pfizer Inc. Pfizer Inc.
  3. Food and Drug Administration Food and Drug Administration
  4. GlaxoSmithKline Inc GlaxoSmithKline Inc
  5. Cervical Cancer
  6. US Food and Drug Administration

Timeline of Coverage

  1. Click to see all coverage from Oct 07, 2009
    18
    October 07, 2009
  2. Click to see all coverage from Oct 08, 2009
    26
    October 08, 2009
  3. Click to see all coverage from Oct 09, 2009
    39
    October 09, 2009
  4. Click to see all coverage from Oct 10, 2009
    5
    October 10, 2009
  5. Click to see all coverage from Oct 11, 2009
    13
    October 11, 2009
  6. Click to see all coverage from Oct 12, 2009
    15
    October 12, 2009
  7. Click to see all coverage from Oct 13, 2009
    46
    October 13, 2009
  8. Click to see all coverage from Oct 14, 2009
    27
    October 14, 2009
  9. Click to see all coverage from Oct 15, 2009
    31
    October 15, 2009
  10. Click to see all coverage from Oct 16, 2009
    115
    October 16, 2009
  11. Click to see all coverage from Oct 17, 2009
    27
    October 17, 2009
  12. Click to see all coverage from Oct 18, 2009
    10
    October 18, 2009
  13. Click to see all coverage from Oct 19, 2009
    84
    October 19, 2009
  14. Click to see all coverage from Oct 20, 2009
    87
    October 20, 2009
  15. Click to see all coverage from Oct 21, 2009
    133
    October 21, 2009
  16. Click to see all coverage from Oct 22, 2009
    183
    October 22, 2009
  17. Click to see all coverage from Oct 23, 2009
    113
    October 23, 2009
  18. Click to see all coverage from Oct 24, 2009
    9
    October 24, 2009
  19. Click to see all coverage from Oct 25, 2009
    12
    October 25, 2009
  20. Click to see all coverage from Oct 26, 2009
    36
    October 26, 2009
  21. Click to see all coverage from Oct 27, 2009
    37
    October 27, 2009
  22. Click to see all coverage from Oct 28, 2009
    19
    October 28, 2009
  23. Click to see all coverage from Oct 29, 2009
    68
    October 29, 2009
  24. Click to see all coverage from Oct 30, 2009
    49
    October 30, 2009
  25. Click to see all coverage from Oct 31, 2009
    5
    October 31, 2009
  26. Click to see all coverage from Nov 01, 2009
    8
    November 01, 2009
  27. Click to see all coverage from Nov 02, 2009
    78
    November 02, 2009
  28. Click to see all coverage from Nov 03, 2009
    77
    November 03, 2009
  29. Click to see all coverage from Nov 04, 2009
    139
    November 04, 2009
  30. Click to see all coverage from Nov 05, 2009
    52
    November 05, 2009
  31. Click to see all coverage from Nov 06, 2009
    35
    November 06, 2009
  32. Click to see all coverage from Nov 07, 2009
    5
    November 07, 2009
  33. Click to see all coverage from Nov 08, 2009
    15
    November 08, 2009
  34. Click to see all coverage from Nov 09, 2009
    50
    November 09, 2009
  35. Click to see all coverage from Nov 10, 2009
    27
    November 10, 2009
  36. Click to see all coverage from Nov 11, 2009
    31
    November 11, 2009
  37. Click to see all coverage from Nov 12, 2009
    33
    November 12, 2009
  38. Click to see all coverage from Nov 13, 2009
    45
    November 13, 2009
  39. Click to see all coverage from Nov 14, 2009
    12
    November 14, 2009
  40. Click to see all coverage from Nov 15, 2009
    35
    November 15, 2009
  41. Click to see all coverage from Nov 16, 2009
    175
    November 16, 2009
  42. Click to see all coverage from Nov 17, 2009
    92
    November 17, 2009
  43. Click to see all coverage from Nov 18, 2009
    74
    November 18, 2009
  44. Click to see all coverage from Nov 19, 2009
    63
    November 19, 2009
  45. Click to see all coverage from Nov 20, 2009
    68
    November 20, 2009
  46. Click to see all coverage from Nov 21, 2009
    23
    November 21, 2009
  47. Click to see all coverage from Nov 22, 2009
    16
    November 22, 2009
  48. Click to see all coverage from Nov 23, 2009
    0
    November 23, 2009

Related Videos

  1. YouTube
  2. Videosurf
  3. Truveo
  1. Loading video...
    1. Watch video
      Merck & Co. Inc. Dassault Falcon 900EX
      13 months ago
    2. Watch video
      Swine Flu Hoax Exposed 2009
      2 months ago
    3. Watch video
      6/24/09 Dow Jones Stocks: SELL 53% or 16, HOLD...
      5 months ago
    4. Watch video
      Gardasil HPV Vaccine
      16 months ago
    5. Watch video
      Deborah Dagit Speech Pt. 1/6
      11 months ago
    6. Watch video
      Whistleblower Exposes The HPV Vaccine Industry
      9 months ago
    View All YouTube Videos »
    1. Watch video
      Vaccine Shot Ingredient: [Abortion
      20 months ago
    2. Watch video
      AMA battles drug ads - Feature Story
      41 months ago
    3. Watch video
      Media Disinfo Eugenics Soft Kill 2009
      3 weeks ago
    4. Watch video
      Arena's Lief Says Lorcaserin `Fits the Bill' fo...
      3 weeks ago
    5. Watch video
      Stock of The Week 4/14/2008 (MRK)
      17 months ago
    6. Watch video
      HC4HR: Comparative Effectiveness Research
      4 months ago
    View All Videosurf Videos »
  3. Powered by Truveo
    1. Watch video
      A Merck/Amylin Tieup Could Suit Both Parties
      1 week ago
    2. Watch video
      MarketWatch Hot Stocks: Merck, J&J In Focus
      5 months ago
    3. Watch video
      MarketWatch Hot Stocks: Pharmaceuticals
      8 months ago
    4. Watch video
      The 20 Best Dividend Plays for 2009
      9 months ago
    5. Watch video
      M&A Outlook
      8 months ago
    6. Watch video
      MarketWatch’s Hot Stocks: DJIA Components
      4 months ago
    View All Truveo Videos »

Related Quotes

  • Previous
  • Next
  • 1/22
  1. Innovation in OLED technology is one of the primary focuses of our institute ... We’re pleased to partner with Applied Materials and Merck to evaluate how our new high-efficiency OLED lighting device structures will perform in an industrial-scale environment.
    SOURCE: PR-Inside.com 5 days ago
  2. We would encourage parents to report any adverse experience associated with any Merck medication or vaccine to their healthcare provider, Merck or the FDA. Patients can report adverse events through their healthcare provider, the Merck National Service Center (1-800-444-2080), or FDA MEDWatch or call 1-...
    SOURCE: Huffington Post 2 weeks ago
  3. We would encourage parents to report any adverse experience associated with any Merck medication or vaccine to their healthcare provider, Merck or the FDA. Patients can report adverse events through their healthcare provider, the Merck National Service Center (1-800-444-2080), or FDA MEDWatch or call 1-...
    SOURCE: Huffington Post 2 weeks ago
  4. The combination of the considerable talents of Schering-Plough and Merck employees across the globe positions Merck to move through this dynamic time for our industry with a clear vision for the future.
    SOURCE: Middle East North Africa Financial Network 2 weeks ago
  5. We are excited about the results that have been obtained thus far in the collaboration with Merck. Considering the complexity of the target, we believe that the results demonstrate the value of having access to hundreds of millions to billions of small molecules for screening ... It is a great pleasure ...
    SOURCE: News-Medical.net 2 weeks ago
  6. We are excited about the results that have been obtained thus far in the collaboration with Merck. Considering the complexity of the target, we believe that the results demonstrate the value of having access to hundreds of millions to billions of small molecules for screening ... It is a great pleasure ...
    SOURCE: News-Medical.net 2 weeks ago
  7. Merck certainly has the right to participate in the government process, but it is important to have watchdog groups involved as well, to ensure that monied interests do not overwhelm the process and that women's health remains the overriding priority.
    SOURCE: Huffington Post 3 weeks ago
  8. Dr. Paul Offit of the Children's Hospital of Philadelphia (CHOP) took home a fortune of at least $29 million as part of a $182 million sale by CHOP of its worldwide royalty interest in the Merck Rotateq vaccine to Royalty Pharma in April of last year.
    SOURCE: NewsTarget - Natural Health & Wellness News 3 weeks ago
  9. The consent order announced today addresses the competitive concerns related to Schering-Plough's proposed acquisition of Merck
    SOURCE: Reuters 3 weeks ago
  10. Cuban children suffering from lymphoblastic leukemia who reject traditional medicines can not be treated with the American product 'Elspar', created specially to treat intolerance ... Consequently, the life expectancy of these children is reduced and their suffering increases. The U.S. government forbid...
    SOURCE: People's Daily Online 3 weeks ago
  11. TC-5214 is a unique form of an old Merck drug called 'mecamylamine,' once used to treat severe hypertension in the 1950s ... Because later research suggested that mecamylamine interacted with brain nicotine receptors, we thought it might have a variety of therapeutic effects similar to nicotine, but wit...
    SOURCE: EurekAlert 3 weeks ago
  12. We are pleased to celebrate success in reaching another milestone with our valued partner, Merck
    SOURCE: Freshnews.com 3 weeks ago
  13. Even in our chemical businesses, which were substantially impacted by the economic crisis, we see a clear trend toward recovery. We now can say with confidence that Merck will deliver what it promised earlier in the year
    SOURCE: Canadian Business Online 3 weeks ago
  14. Merck will continue to argue against class certification of personal injury claims in Canada because each plaintiff’s case is unique
    SOURCE: Bloomberg.com 1 month ago
  15. This quarter we delivered operational top-line growth, reconciled bottom-line growth and major pipeline successes. We powered through - even in the face of tough global economic and currency headwinds ... As we near the anticipated close of our combination with Merck, we are proud of how our colleagues ...
    SOURCE: Street Insider 1 month ago
  16. Merck Forest rarely has problems and there are lots of very content people enjoying the cabins
    SOURCE: Bennington Banner 1 month ago
  17. Merck's ongoing commitment to the HIV community is demonstrated through , which highlights the importance for people living with HIV to have a positive outlook on life while effectively managing their disease ... Philadelphia has been greatly impacted by HIV and I am proud to be partnering with Merck to...
    SOURCE: Freshnews.com 1 month ago
  18. For example, rimonabant, a Sanofi-Aventis drug once viewed a surefire blockbuster, failed to win F.D.A. approval in 2007 because of links to depression and suicidalthoughts. The drug, also known as Acomplia, was then taken off the market in Europe. And Merck and Pfizer abandoned their efforts to develop...
    SOURCE: Newsvine 1 month ago
  19. We’re honored to share this award recognizing the creative and collaborative efforts of the Merck/Phase Forward team
    SOURCE: Freshnews.com 1 month ago
  20. Our commercial success to date allows us to make a significant investment in establishing a strong presence in the high-growth NGS market ... Part of that investment is the recruitment of a team of new scientists, led by Dr. Christopher Raymond, formerly of Rosetta Inpharmatics LLC, a wholly owned subsi...
    SOURCE: News-Medical.net 1 month ago
  21. By the summer of 2005, [Schering-Plough/Merck’s] marketing division [was] so successful that [VYTORIN was] already a blockbuster drug. There was only downside [to analyzing the results of ENHANCE trial].
    SOURCE: PharmaGossip 1 month ago
  22. The Merck health economic analysis shows that vaccinating males with Gardasil is cost effective at a per quality-adjusted life year of less than $25,000
    SOURCE: MSN Health 1 month ago
View All »